Patent · US Expired

Thrombopoietin mimetics

US7241783B2 · kind B2 · utility

1Cited by
3References
1Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 19, 2001
Grant dateJul 10, 2007
Priority date
Expiry dateNov 28, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected substituted thiosemicarbazone derivative.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.